Three versus six cycles of adjuvant platinum-based chemotherapy in early stage clear cell ovarian carcinoma–a multi-institutional cohort

EN Prendergast, M Holzapfel, JJ Mueller… - Gynecologic …, 2017 - Elsevier
Objectives To determine if 6 versus 3 cycles of adjuvant platinum-based chemotherapy with
or without taxane impacts survival in early stage ovarian clear cell carcinoma (OCCC) …

Venous thromboembolism in patients receiving extended pharmacologic prophylaxis after robotic surgery for endometrial cancer

JS Kim, KA Mills, J Fehniger, C Liao… - International Journal of …, 2017 - ijgc.bmj.com
Objective This study aims to determine the rate of postoperative venous thromboembolism
(VTE) in endometrial cancer patients undergoing robotic hysterectomy with or without …

Clinical outcomes in ovarian cancer patients receiving three versus more cycles of chemotherapy after neoadjuvant treatment and interval cytoreductive surgery

JS Kim, MI Liang, EN Prendergast… - International Journal of …, 2019 - ijgc.bmj.com
Objectives To compare clinical outcomes for stage IIIC and IV ovarian cancer patients
receiving neoadjuvant chemotherapy and interval cytoreductive surgery followed by up to …